ACADIA HEALTHCARE CO INC (ACHC)
US00404A1097 - Common Stock
Overall ACHC gets a fundamental rating of 4 out of 10. We evaluated ACHC against 107 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of ACHC while its profitability can be described as average. ACHC has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
ACHC had positive earnings in the past year.
In the past year ACHC had a positive cash flow from operations.
In multiple years ACHC reported negative net income over the last 5 years.
In the past 5 years ACHC always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 4.78%, ACHC is doing good in the industry, outperforming 78.10% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.26%, ACHC is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.74%, ACHC is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ACHC is in line with the industry average of 8.15%.
The last Return On Invested Capital (7.74%) for ACHC is above the 3 year average (7.51%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.78% | ||
| ROE | 9.26% | ||
| ROIC | 7.74% |
ROA(3y)3.02%
ROA(5y)0.06%
ROE(3y)5.5%
ROE(5y)-2.91%
ROIC(3y)7.51%
ROIC(5y)6.2%
1.3 Margins
ACHC's Profit Margin of 8.99% is amongst the best of the industry. ACHC outperforms 92.38% of its industry peers.
ACHC has a better Operating Margin (17.42%) than 98.10% of its industry peers.
In the last couple of years the Operating Margin of ACHC has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.42% | ||
| PM (TTM) | 8.99% | ||
| GM | N/A |
OM growth 3Y2.8%
OM growth 5Y1.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACHC is destroying value.
The number of shares outstanding for ACHC has been increased compared to 1 year ago.
The number of shares outstanding for ACHC has been increased compared to 5 years ago.
Compared to 1 year ago, ACHC has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.80, we must say that ACHC is in the distress zone and has some risk of bankruptcy.
ACHC has a Altman-Z score (1.80) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.60 indicates that ACHC is somewhat dependend on debt financing.
ACHC's Debt to Equity ratio of 0.60 is in line compared to the rest of the industry. ACHC outperforms 54.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.8 |
ROIC/WACC0.97
WACC7.98%
2.3 Liquidity
A Current Ratio of 1.07 indicates that ACHC should not have too much problems paying its short term obligations.
The Current ratio of ACHC (1.07) is worse than 75.24% of its industry peers.
ACHC has a Quick Ratio of 1.06. This is a normal value and indicates that ACHC is financially healthy and should not expect problems in meeting its short term obligations.
ACHC has a Quick ratio of 1.06. This is in the lower half of the industry: ACHC underperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 7.01% over the past year.
Measured over the past years, ACHC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.90% on average per year.
Looking at the last year, ACHC shows a quite strong growth in Revenue. The Revenue has grown by 9.13% in the last year.
The Revenue has been growing by 8.99% on average over the past years. This is quite good.
EPS 1Y (TTM)7.01%
EPS 3Y7.38%
EPS 5Y8.9%
EPS Q2Q%0%
Revenue 1Y (TTM)9.13%
Revenue growth 3Y11.91%
Revenue growth 5Y8.99%
Sales Q2Q%8.7%
3.2 Future
The Earnings Per Share is expected to grow by 8.50% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.66% on average over the next years. This is quite good.
EPS Next Y0.97%
EPS Next 2Y3.07%
EPS Next 3Y5.5%
EPS Next 5Y8.5%
Revenue Next Year8.45%
Revenue Next 2Y8.85%
Revenue Next 3Y9.03%
Revenue Next 5Y9.66%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.63 indicates a correct valuation of ACHC.
Compared to the rest of the industry, the Price/Earnings ratio of ACHC indicates a rather cheap valuation: ACHC is cheaper than 86.67% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.41. ACHC is valued rather cheaply when compared to this.
ACHC is valuated correctly with a Price/Forward Earnings ratio of 12.16.
Based on the Price/Forward Earnings ratio, ACHC is valued cheaper than 83.81% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, ACHC is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.63 | ||
| Fwd PE | 12.16 |
4.2 Price Multiples
80.00% of the companies in the same industry are more expensive than ACHC, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.58 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACHC does not grow enough to justify the current Price/Earnings ratio.
ACHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)13.01
PEG (5Y)1.42
EPS Next 2Y3.07%
EPS Next 3Y5.5%
5. Dividend
5.1 Amount
No dividends for ACHC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ACADIA HEALTHCARE CO INC
NASDAQ:ACHC (1/3/2025, 8:18:14 PM)
After market: 44.32 0 (0%)44.32
+3.55 (+8.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners105.72%
Inst Owner Change2.17%
Ins Owners1%
Ins Owner Change-0.12%
Market Cap4.12B
Analysts83.16
Price Target61.88 (39.62%)
Short Float %7.6%
Short Ratio3.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.59%
Min EPS beat(2)-1.26%
Max EPS beat(2)2.44%
EPS beat(4)3
Avg EPS beat(4)2.12%
Min EPS beat(4)-1.26%
Max EPS beat(4)5.12%
EPS beat(8)6
Avg EPS beat(8)1.16%
EPS beat(12)9
Avg EPS beat(12)9.91%
EPS beat(16)12
Avg EPS beat(16)12.81%
Revenue beat(2)0
Avg Revenue beat(2)-1.46%
Min Revenue beat(2)-2.42%
Max Revenue beat(2)-0.51%
Revenue beat(4)1
Avg Revenue beat(4)-1.55%
Min Revenue beat(4)-3.36%
Max Revenue beat(4)0.09%
Revenue beat(8)4
Avg Revenue beat(8)-0.49%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)5
Avg Revenue beat(16)-4.74%
PT rev (1m)-5.33%
PT rev (3m)-30.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.44%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-3.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.41%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.63 | ||
| Fwd PE | 12.16 | ||
| P/S | 1.32 | ||
| P/FCF | N/A | ||
| P/OCF | 31.83 | ||
| P/B | 1.36 | ||
| P/tB | 5.94 | ||
| EV/EBITDA | 8.58 |
EPS(TTM)3.51
EY7.92%
EPS(NY)3.64
Fwd EY8.22%
FCF(TTM)-5.34
FCFYN/A
OCF(TTM)1.39
OCFY3.14%
SpS33.62
BVpS32.64
TBVpS7.47
PEG (NY)13.01
PEG (5Y)1.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.78% | ||
| ROE | 9.26% | ||
| ROCE | 10.34% | ||
| ROIC | 7.74% | ||
| ROICexc | 7.86% | ||
| ROICexgc | 14.33% | ||
| OM | 17.42% | ||
| PM (TTM) | 8.99% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)3.02%
ROA(5y)0.06%
ROE(3y)5.5%
ROE(5y)-2.91%
ROIC(3y)7.51%
ROIC(5y)6.2%
ROICexc(3y)7.7%
ROICexc(5y)6.4%
ROICexgc(3y)16.2%
ROICexgc(5y)12.86%
ROCE(3y)10.04%
ROCE(5y)8.28%
ROICexcg growth 3Y24.65%
ROICexcg growth 5Y20.82%
ROICexc growth 3Y18.77%
ROICexc growth 5Y16.69%
OM growth 3Y2.8%
OM growth 5Y1.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.62 | ||
| Cap/Depr | 430.27% | ||
| Cap/Sales | 20.04% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 18.76% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z | 1.8 |
F-Score5
WACC7.98%
ROIC/WACC0.97
Cap/Depr(3y)267.08%
Cap/Depr(5y)260.42%
Cap/Sales(3y)12.13%
Cap/Sales(5y)11.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.01%
EPS 3Y7.38%
EPS 5Y8.9%
EPS Q2Q%0%
EPS Next Y0.97%
EPS Next 2Y3.07%
EPS Next 3Y5.5%
EPS Next 5Y8.5%
Revenue 1Y (TTM)9.13%
Revenue growth 3Y11.91%
Revenue growth 5Y8.99%
Sales Q2Q%8.7%
Revenue Next Year8.45%
Revenue Next 2Y8.85%
Revenue Next 3Y9.03%
Revenue Next 5Y9.66%
EBIT growth 1Y11.17%
EBIT growth 3Y15.03%
EBIT growth 5Y10.64%
EBIT Next Year58.03%
EBIT Next 3Y23.25%
EBIT Next 5YN/A
FCF growth 1Y-830.92%
FCF growth 3Y-52.6%
FCF growth 5Y-6.79%
OCF growth 1Y-64.56%
OCF growth 3Y-7.48%
OCF growth 5Y2.23%